Covered recipient · General Payments record
CAROL A PILOTE
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2022–2024
$632.51
- Reported across 36 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $313.33 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $93.02 | 4 |
| Astellas Pharma US Inc | $60.70 | 3 |
| DEXCOM, INC. | $55.24 | 3 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $54.78 | 3 |
| Lilly USA, LLC | $30.70 | 2 |
| Abbott Laboratories | $18.89 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $18.89 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125369747 | CMS |
| ABBVIE INC. | $27.05 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107851931 | CMS |
| ABBVIE INC. | $27.37 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107851933 | CMS |
| ABBVIE INC. | $23.07 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107851935 | CMS |
| ABBVIE INC. | $15.53 | 09/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107851937 | CMS |
| Astellas Pharma US Inc | $19.33 | 01/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139476822 | CMS |
| Astellas Pharma US Inc | $22.91 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139499782 | CMS |
| Astellas Pharma US Inc | $18.46 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139551585 | CMS |
| Dexcom, Inc. | $19.46 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153353238 | CMS |
| Dexcom, Inc. | $17.41 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153353240 | CMS |
| Dexcom, Inc. | $18.37 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153353242 | CMS |
| Lilly USA, LLC | $13.70 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135577500 | CMS |
| Lilly USA, LLC | $17.00 | 04/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135576990 | CMS |
| Novartis Pharmaceuticals Corporation | $19.40 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087298049 | CMS |
| Novartis Pharmaceuticals Corporation | $17.99 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087298069 | CMS |
| Novartis Pharmaceuticals Corporation | $17.39 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087298109 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.